Home › Funds › Propel Bio Management, LLC › SGMT
Propel Bio Management, LLC position in SGMT
SAGIMET BIOSCIENCES INC COM SER A · Health Care
Propel Bio Management, LLC reported holding 125,878 shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A) in its Q2 2026 13F filing — a position valued at US$973K, representing 0.51% of its reported portfolio and ranking #29 among its reported holdings. Propel Bio Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's SGMT position evolved
Propel Bio Management, LLC first disclosed a stake in SGMT in Q2 2026 at 125,878 shares (US$973K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 125.88K | $973.04K | New |
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC COM SER A) is a Health Care company. 59 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 2.93M sh · $22.63M · Q2 2026
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- Affinity Asset Advisors, LLC 2.50M sh · $19.31M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Saturn V Capital Management LP 1.48M sh · $11.44M · Q2 2026
- Blue Owl Capital Holdings LP 1.26M sh · $9.74M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
- Pale Fire Capital SE 221.88K sh · $1.72M · Q2 2026
- Sofinnova Investments, Inc. 166.67K sh · $1.29M · Q2 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held SGMT?
Propel Bio Management, LLC has disclosed SGMT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Propel Bio Management, LLC's current position in SGMT?
As of Q2 2026, Propel Bio Management, LLC holds 125.88K shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A), valued at $973.04K, representing 0.51% of its reported portfolio and ranking #29.
Has Propel Bio Management, LLC been buying or selling SGMT?
In the latest 13F filing (Q2 2026), Propel Bio Management, LLC newly opened its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.